Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Sarcoma, Kaposi

• Phase II Study of Pacritinib in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome (KICS)
• A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
• A Phase II Single-arm Study of Pembrolizumab Plus Lenvatinib in Previously Treated Classic Kaposi Sarcoma
• A Study of Propranolol to Treat Kaposi Sarcoma
• Preliminary Assessment of Safety and Tolerability of Dostarlimab in Combination Antiretroviral Therapy (cART) Refractory HIV Associated Kaposi Sarcoma
• Doxil/Caelyx BE Study
• Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma
• L19IL2/L19TNF in Skin Cancer Patients
• Different Doses of Sirolimus for the Maintenance Treatment of Kaposiform Hemangioendothelioma
• Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma
• Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV
• Efficacy and Safety of Different Concentrations of Sirolimus in the Treatment of Kaposiform Hemangioendothelioma.
• Pomalidomide Treatment in Patients With Kaposi Sarcoma
• Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
• Guided Discontinuation Versus Maintenance Treatment of Sirolimus in Pediatric Patients With Kaposiform Hemangioendothelioma
• SCMC Trial on KHE With KMP (V.2020)
• Trial of Ixazomib for Kaposi Sarcoma
• NHS-IL12 Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma
• Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma
• Phase II Multicenter Study of Talimogene Laherparepvec in Classic or Endemic Kaposi Sarcoma
• Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted Angioma
• A Study of sEphB4-HSA in Kaposi Sarcoma
• Rituximab Hyaluronidase in Combination With Chemotherapy in Treating Aggressive B-cell Lymphoma in Uganda
• Pomalidomide in Treating Patients With Kaposi Sarcoma and Human Immunodeficiency Virus Infection
• Evaluating Quality of Life in Patients With AIDS-Associated Kaposi Sarcoma Treated With Bleomycin and Vincristine
• Phase II Multicentric Study of Pembrolizumab in Classic or Endemic Kaposi's Sarcoma
• Intra-lesional Nivolumab Therapy for Limited Cutaneous Kaposi Sarcoma
• Valganciclovir Four Weeks Prior to cART Initiation Compared to Standard Therapy for Disseminated Kaposi Sarcoma
• Nivolumab and Ipilimumab in Classical Kaposi Sarcoma (CKS)
• Sirolimus Versus Sirolimus Plus Prednisolone for Kaposiform Hemangioendothelioma
• An Evaluation of Tc 99m Tilmanocept by Intravenous (IV) and Subcutaneous (SC) Injection in Kaposi Sarcoma (KS)
• Nelfinavir Mesylate in Treating Patients With Kaposi Sarcoma
• Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma
• Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer
• Early Phase Evaluation of ABC294640 in Patients With Refractory/Relapsed Diffuse Large B-cell Lymphoma or Kaposi Sarcoma
• Evaluation of Tc 99m Tilmanocept Localization in Primary Cutaneous Kaposi's Sarcoma and Lymphatic Drainage by SPECT/CT
• Gamma Secretase Inhibitor PF-03084014 in Treating Patients With AIDS-Associated Kaposi Sarcoma
• A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors
• Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors
• A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's Sarcoma
• A Study of Selumetinib in Patients With Kaposi's Sarcoma
• Pomalidomide for Kaposi Sarcoma in People With or Without HIV
• A Phase II Study With Tumor Molecular Pharmacodynamic (MPD) Evaluation of Oral mTOR-inhibitor Everolimus (RAD001) 10 mg Daily in Patients Suffering From Classic or Endemic Kaposi's Sarcoma
• Antiretroviral Therapy (ART) Alone or With Delayed Chemo Versus ART With Immediate Chemo for Limited AIDS-related Kaposi's Sarcoma
• Intralesional Bevacizumab for Treating AIDS-associated Kaposi´s Sarcoma of the Larynx, Pharynx and Oral Cavity
• Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS)
• Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma
• Treatment With Indinavir and Chemotherapy for Advanced Classical Kaposi's Sarcoma
• Lenalidomide in Treating Patients With AIDS-Associated Kaposi's Sarcoma
• Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma
• Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies
• Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults With Advanced Kaposi s Sarcoma
• A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in Zimbabwe
• PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma
• Sunitinib Malate in Treating East African Patients With Kaposi Sarcoma
• Sirolimus in Treating Patients With HIV-Related Kaposi's Sarcoma
• Anti-Retrovirals for Kaposi's Sarcoma
• Liposomal Daunorubicin in Treating Patients With HIV-Related Kaposi's Sarcoma
• HIV/AIDS Kaposis Sarcoma: Comparison of Response to HAART vs HAART Plus CXT
• Treatment of Classical Non-HIV-Related Kaposi's Sarcoma With the Antiviral Drug Indinavir
• Nicotine Skin Patch in Treating Patients With Kaposi's Sarcoma
• BAY 43-9006 (Sorafenib) to Treat Patients With Kaposi's Sarcoma
• Valganciclovir in Treating Patients With Classic Non-HIV-Associated Kaposi's Sarcoma
• Imatinib Mesylate in Treating Patients With HIV-Related Kaposi's Sarcoma
• Valproic Acid in Treating Patients With Kaposi's Sarcoma
• Halofuginone Hydrobromide in Treating Patients With HIV-Related Kaposi's Sarcoma
• A Safety/Efficacy Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent CD30+ Hematologic Malignancies
• BMS-275291 in Treating Patients With HIV-Related Kaposi's Sarcoma
• A Phase II Trial of COL-3 in Patients With HIV Related Kaposi's Sarcoma
• Liposomal Doxorubicin and Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma
• Antiviral Therapy in Treating Patients With Kaposi's Sarcoma With or Without HIV Infection
• Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma
• Thalidomide in Treating Patients With HIV-Associated Kaposi's Sarcoma
• EMD 121974 in Treating Patients With HIV-Related Kaposi's Sarcoma
• SU5416 in Patients With AIDS-Related Kaposi's Sarcoma Who Have Not Responded to Treatment
• SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma
• SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma
• Paclitaxel Compared With Doxorubicin in Treating Patients With Advanced AIDS-Related Kaposi's Sarcoma
• Liposomal Doxorubicin and PSC 833 in Treating Patients With AIDS-Related Kaposi's Sarcoma or Other Advanced Cancers
• Paclitaxel in Treating Patients With AIDS-Related Kaposi's Sarcoma
• Doxorubicin in Treating Patients With AIDS-Related Kaposi's Sarcoma
• Safety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS Patients
• A Study of ALRT 1057 Topical Gel in Patients With AIDS-Related Kaposi's Sarcoma
• The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kaposi's Sarcoma
• A Study of Tecogalan Sodium
• A Study of DOX-SL in the Treatment of AIDS-Related Kaposi's Sarcoma
• A Comparison of DOX-SL Versus Adriamycin Plus Bleomycin Plus Vincristine in the Treatment of Severe AIDS-Related Kaposi's Sarcoma
• A Study of Ro 24-7429 in Patients With HIV-Related Kaposi's Sarcoma
• A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's Sarcoma
• Phase II Study of Intravenous Novantrone(R) in the Treatment of AIDS Related Kaposi's Sarcoma
• Safety and Effectiveness of Giving SU5416 to HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma
• A Study of Targretin Capsules in Patients With AIDS-Related Kaposi's Sarcoma
• Paclitaxel in Advanced Refractory Kaposi's Sarcoma (AIDS-KS): A Phase II Trial of Paclitaxel From Baker Norton Pharmaceuticals
• A Study of ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma
• A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3
• Photodynamic Therapy Clinical Trial For Cutaneous AIDS-Related Kaposi's Sarcoma Study Summary.
• Topical Use of 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenylhydrazone (A-007) in the Treatment of Advanced Malignancies Including Kaposi's Sarcoma and Lymphoproliferative Disorders
• Use of Stealth Liposomal Doxorubicin HCl ( DOX-SL ) in the Treatment of Moderate to Severe AIDS-Related Kaposi's Sarcoma.
• A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Twice Weekly for 21 Days.
• A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Weekly x 4
• A Phase I Trial of Tecogalan Sodium (DS-4152) Administered as an Infusion Every 21 Days
• A Pilot Study of OPC-8212 (Vesnarinone) in Persons With AIDS-Related Kaposi's Sarcoma
• Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma
• A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma.
• Twins Study of Gene Therapy for HIV Infection
• The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposi's Sarcoma
• A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's Sarcoma
• Comparison of Liposomal Doxorubicin Used Alone or in Combination With Bleomycin Plus Vincristine in the Treatment of Kaposi's Sarcoma in Patients With AIDS
• A Study of Doxorubicin in the Treatment of AIDS-Related Kaposi's Sarcoma
• A Study of AZT in HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma
• A Study of Chemotherapy Plus Azidothymidine in the Treatment of Kaposi's Sarcoma in Patients With AIDS
• A Study of Chemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposi's Sarcoma
• Phase II Evaluation of Low-Dose Oral Etoposide for the Treatment of Relapsed or Progressed AIDS-Related Kaposi's Sarcoma After Systemic Chemotherapy
• A Phase I/II Study of Recombinant Interleukin-4 in AIDS and Kaposi's Sarcoma
• A Phase I Study of TNP-470 in the Treatment of AIDS-Associated Kaposi's Sarcoma
• A Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and Lymphoblastoid) in the Treatment of AIDS-Associated Kaposi's Sarcoma
• Open Label Phase I Study To Evaluate the Safety of Combination Therapy With AZT and Interferon-Beta in Patients With AIDS Related Kaposi's Sarcoma
• A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rHuGM-CSF), Recombinant Alpha Interferon and Azidothymidine (AZT) in AIDS-Associated Kaposi's Sarcoma
• Phase II Study of Zidovudine and Recombinant Alpha-2A Interferon in the Treatment of Patients With AIDS-Associated Kaposi's Sarcoma
• A Phase I Study of the Combination of Recombinant GM-CSF, AZT, and Chemotherapy (ABV) (Adriamycin, Bleomycin, Vincristine) in AIDS and Kaposi's Sarcoma
• Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma